Latest Insider Transactions at 3 D Systems Corp (DDD)
This section provides a real-time view of insider transactions for 3 D Systems Corp (DDD). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of 3D SYSTEMS CORP to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of 3D SYSTEMS CORP's insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Aug 16
2021
|
Jeffrey A Graves President and CEO |
BUY
Open market or private purchase
|
Direct |
4,260
+0.81%
|
$123,540
$29.37 P/Share
|
Jul 26
2021
|
Andrew Martin Johnson EVP, Chief Legal Officer & Sec |
SELL
Open market or private sale
|
Direct |
4,000
-1.89%
|
$100,000
$25.8 P/Share
|
Jul 17
2021
|
Menno Ellis EVP, Healthcare Solutions |
SELL
Payment of exercise price or tax liability
|
Direct |
1,372
-1.11%
|
$34,300
$25.9 P/Share
|
Jun 28
2021
|
David K Leigh EVP & CTO (Additive Mfg) |
BUY
Grant, award, or other acquisition
|
Direct |
20,421
+49.24%
|
-
|
Jun 25
2021
|
Andrew Martin Johnson EVP, Chief Legal Officer & Sec |
SELL
Open market or private sale
|
Direct |
4,000
-1.85%
|
$152,000
$38.2 P/Share
|
Jun 13
2021
|
Jeff Blank EVP, Engineering and Prod Dev |
SELL
Payment of exercise price or tax liability
|
Direct |
985
-1.89%
|
$28,565
$29.35 P/Share
|
May 26
2021
|
Jeffrey A Graves President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
27,977
-5.11%
|
$811,333
$29.37 P/Share
|
May 26
2021
|
Andrew Martin Johnson EVP, Chief Legal Officer & Sec |
SELL
Open market or private sale
|
Direct |
4,000
-1.82%
|
$108,000
$27.29 P/Share
|
May 24
2021
|
Michael S Crimmins Former SVP and CAO |
BUY
Grant, award, or other acquisition
|
Direct |
9,114
+50.0%
|
-
|
May 19
2021
|
Jeffrey A Graves President and CEO |
BUY
Open market or private purchase
|
Direct |
4,100
+0.74%
|
$98,400
$24.71 P/Share
|
May 18
2021
|
Malissia Clinton Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,007
+10.97%
|
-
|
May 18
2021
|
William Edward Curran Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,007
+5.21%
|
-
|
May 18
2021
|
Thomas W Erickson Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,007
+4.61%
|
-
|
May 18
2021
|
Vasant Padmanabhan Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,007
+21.51%
|
-
|
May 18
2021
|
John J Tracy Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,007
+9.77%
|
-
|
May 18
2021
|
William David Humes Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,007
+8.05%
|
-
|
May 18
2021
|
Jim D Kever Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,007
+1.56%
|
-
|
May 18
2021
|
Kevin S Moore Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,007
+40.73%
|
-
|
May 18
2021
|
Charles G Mcclure Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,007
+9.56%
|
-
|
May 18
2021
|
Jeffrey Wadsworth Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,007
+9.56%
|
-
|
May 17
2021
|
Menno Ellis EVP, Healthcare Solutions |
SELL
Open market or private sale
|
Direct |
10,573
-7.9%
|
$232,606
$22.49 P/Share
|
May 17
2021
|
Jeff Blank EVP, Engineering and Prod Dev |
SELL
Payment of exercise price or tax liability
|
Direct |
1,618
-3.01%
|
$35,596
$22.71 P/Share
|
May 14
2021
|
Jeff Blank EVP, Engineering and Prod Dev |
SELL
Open market or private sale
|
Direct |
10,000
-15.67%
|
$210,000
$21.9 P/Share
|
Mar 01
2021
|
Anthony Grabenau Former PAO |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+12.48%
|
-
|
Mar 01
2021
|
Menno Ellis EVP, Healthcare Solutions |
SELL
Payment of exercise price or tax liability
|
Direct |
879
-0.65%
|
$33,402
$38.79 P/Share
|
Mar 01
2021
|
Charles W Hull EVP & Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,085
-0.72%
|
$41,230
$38.79 P/Share
|
Mar 01
2021
|
Andrew Martin Johnson EVP, Chief Legal Officer & Sec |
SELL
Payment of exercise price or tax liability
|
Direct |
1,652
-0.75%
|
$62,776
$38.79 P/Share
|
Feb 23
2021
|
Andrew Martin Johnson EVP, Chief Legal Officer & Sec |
SELL
Open market or private sale
|
Direct |
4,000
-1.77%
|
$140,000
$35.0 P/Share
|
Feb 16
2021
|
Jeff Blank EVP, Engineering and Prod Dev |
SELL
Payment of exercise price or tax liability
|
Direct |
826
-1.28%
|
$38,822
$47.85 P/Share
|
Feb 16
2021
|
Menno Ellis EVP, Healthcare Solutions |
SELL
Payment of exercise price or tax liability
|
Direct |
5,797
-2.08%
|
$272,459
$47.85 P/Share
|
Feb 16
2021
|
Charles W Hull EVP & Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,132
-1.65%
|
$241,204
$47.85 P/Share
|
Feb 16
2021
|
Andrew Martin Johnson EVP, Chief Legal Officer & Sec |
SELL
Payment of exercise price or tax liability
|
Direct |
8,083
-1.74%
|
$379,901
$47.85 P/Share
|
Feb 15
2021
|
Anthony Grabenau Former PAO |
BUY
Grant, award, or other acquisition
|
Direct |
5,533
+26.9%
|
-
|
Feb 01
2021
|
Jeffrey A Graves President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
10,389
+1.86%
|
-
|
Feb 01
2021
|
Jagtar Narula EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,530
+0.46%
|
-
|
Feb 01
2021
|
Reji Puthenveetil EVP, Additive Solutions & CCO |
SELL
Grant, award, or other acquisition
|
Direct |
1,292
-0.84%
|
-
|
Jan 22
2021
|
Andrew Martin Johnson EVP, Chief Legal Officer & Sec |
SELL
Open market or private sale
|
Direct |
4,000
-1.68%
|
$120,000
$30.1 P/Share
|
Jan 12
2021
|
Jagtar Narula EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
38,454
+10.5%
|
-
|
Jan 12
2021
|
Jeff Blank EVP, Engineering and Prod Dev |
BUY
Grant, award, or other acquisition
|
Direct |
15,381
+19.22%
|
-
|
Jan 12
2021
|
Menno Ellis EVP, Healthcare Solutions |
BUY
Grant, award, or other acquisition
|
Direct |
38,454
+21.48%
|
-
|
Jan 12
2021
|
Jeffrey A Graves President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
105,748
+16.43%
|
-
|
Jan 12
2021
|
Charles W Hull EVP & Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
38,453
+11.51%
|
-
|
Jan 12
2021
|
Andrew Martin Johnson EVP, Chief Legal Officer & Sec |
BUY
Grant, award, or other acquisition
|
Direct |
44,222
+8.63%
|
-
|
Jan 12
2021
|
Reji Puthenveetil EVP, Additive Solutions & CCO |
BUY
Grant, award, or other acquisition
|
Direct |
38,454
+20.36%
|
-
|
Dec 31
2020
|
Jeffrey A Graves President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
26,856
-5.85%
|
$268,560
$10.48 P/Share
|
Dec 30
2020
|
Malissia Clinton Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,647
+7.86%
|
-
|
Dec 23
2020
|
Andrew Martin Johnson EVP, Chief Legal Officer & Sec |
SELL
Open market or private sale
|
Direct |
4,000
-2.03%
|
$44,000
$11.94 P/Share
|
Dec 14
2020
|
Menno Ellis EVP, Healthcare Solutions |
SELL
Payment of exercise price or tax liability
|
Direct |
2,028
-1.95%
|
$20,280
$10.36 P/Share
|
Dec 14
2020
|
Charles W Hull EVP & Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,141
-2.6%
|
$31,410
$10.36 P/Share
|
Dec 14
2020
|
Andrew Martin Johnson EVP, Chief Legal Officer & Sec |
SELL
Payment of exercise price or tax liability
|
Direct |
2,450
-1.23%
|
$24,500
$10.36 P/Share
|